SYNVISC(HYLAN G-F 20)
FDA premarket approval P940015/S007 · decided 2002-04-26
Approval details
- PMA number
- P940015
- Supplement
- S007
- Supplement type
- Special (Immediate Track)
- Supplement reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Trade name
- SYNVISC(HYLAN G-F 20)
- Generic name
- Acid, hyaluronic, intraarticular
- Applicant
- Sanofi Genzyme Corp.
- Date received
- 2002-03-29
- Decision date
- 2002-04-26
- Days to decision
- 28 days
- Decision code
- APPR
- Product code
- MOZ
- Advisory committee
- Orthopedic
- Expedited review
- No
- Location
- Cambridge, MA
- Statement
- APPROVAL FOR THE ADDITION OF THE FOLLOWING STATEMENT TO THE SYNVISC PHYSICIAN PACKAGE INSERT: "PRECAUTION: DO NOT OVER TIGHTEN OR APPLY EXCESSIVE LEVERAGE WHEN ATTACHING THE NEEDLE OR REMOVING THE NEEDLE GUARD, AS THIS MAY BREAK THE TIP OF THE SYRINGE."
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.